Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00MLW
|
|||
| Former ID |
DIB005408
|
|||
| Drug Name |
Triheptanoin
|
|||
| Synonyms |
Triheptanoin; 620-67-7; GLYCERYL TRIHEPTANOATE; Propane-1,2,3-triyl triheptanoate; Triheptylin; Trienanthoin; Trioenanthoin; Triheptanoic glyceride; Glycerol triheptanoate; UNII-2P6O7CFW5K; Propane-1,2,3-triyl trisheptanoate; BRN 1807724; EINECS 210-647-2; 2P6O7CFW5K; 3-02-00-00769 (Beilstein Handbook Reference); Heptanoin, tri- (6CI,7CI,8CI); 2,3-di(heptanoyloxy)propyl heptanoate; W-109093; Dermofeel TC 7; Lanol 37T; 1,2,3-propanetriyl triheptanoate; Trienantin; UX007; Glyceryl trienanthate; Triheptanoin [USAN]; Heptanoic acid, 1,
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Long-chain fatty acid oxidation disorder [ICD-11: BC43.10] | Approved | [1] | |
| Genetic epileptic syndromes with variable age of onset [ICD-11: 8A61.4Y] | Phase 3 | [2], [3] | ||
| Company |
Ultragenyx
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H44O6
|
|||
| Canonical SMILES |
CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
|
|||
| InChI |
1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3
|
|||
| InChIKey |
PJHKBYALYHRYSK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 620-67-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020 | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.